Literature DB >> 10943933

Transmission of electric and magnetic foetal cardiac signals in a case of ectopia cordis: the dominant role of the vernix. caseosa.

R T Wakai1, J M Lengle, A C Leuthold.   

Abstract

Foetal electrocardiograms (fECGs) and foetal magnetocardiograms (fMCGs) were recorded in the 26th, 29th and 31st weeks of gestation from a foetus with ectopia cordis-a rare condition in which the heart lies outside the chest wall. This provided an opportunity to study foetal cardiograms uninfluenced by the insulating effects of the foetal skin and vernix caseosa. The fECG of the ectopia cordis foetus was striking. Unlike recordings from age-matched normal foetuses, recordings from this subject had very high signal-to-noise ratio and showed no anomalous signal transmission properties. In contrast, fMCGs recorded from the ectopia cordis foetus and normal foetuses were largely similar. Both showed high signal-to-noise ratio and signal transmission properties consistent with volume conduction. The findings corroborate the hypothesis that high foetal skin resistance due primarily to the vernix caseosa is responsible for the low amplitude and anomalous transmission properties of the normal fECG, and demonstrate that the fMCG is relatively insensitive to conductivity inhomogeneities.

Entities:  

Mesh:

Year:  2000        PMID: 10943933     DOI: 10.1088/0031-9155/45/7/320

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  11 in total

Review 1.  Fetal cardiac arrhythmia detection and in utero therapy.

Authors:  Janette F Strasburger; Ronald T Wakai
Journal:  Nat Rev Cardiol       Date:  2010-05       Impact factor: 32.419

Review 2.  Diagnosis and treatment of fetal arrhythmia.

Authors:  Annette Wacker-Gussmann; Janette F Strasburger; Bettina F Cuneo; Ronald T Wakai
Journal:  Am J Perinatol       Date:  2014-05-23       Impact factor: 1.862

3.  Segmented independent component analysis for improved separation of fetal cardiac signals from nonstationary fetal magnetocardiograms.

Authors:  Luiz O Murta; Mauro G Guzo; Eder R Moraes; Oswaldo Baffa; Ronald T Wakai; Silvia Comani
Journal:  Biomed Tech (Berl)       Date:  2015-06       Impact factor: 1.411

4.  Magnetocardiography with a modular spin-exchange relaxation-free atomic magnetometer array.

Authors:  R Wyllie; M Kauer; G S Smetana; R T Wakai; T G Walker
Journal:  Phys Med Biol       Date:  2012-04-13       Impact factor: 3.609

5.  Detection of atrial-flutter and atrial-fibrillation waveforms by fetal magnetocardiogram.

Authors:  A Kandori; T Hosono; T Kanagawa; S Miyashita; Y Chiba; M Murakami; T Miyashita; K Tsukada
Journal:  Med Biol Eng Comput       Date:  2002-03       Impact factor: 2.602

6.  A systematic scoping review to identify the design and assess the performance of devices for antenatal continuous fetal monitoring.

Authors:  Kajal K Tamber; Dexter J L Hayes; Stephen J Carey; Jayawan H B Wijekoon; Alexander E P Heazell
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

7.  Phase plane based identification of fetal heart rate patterns.

Authors:  Rathinaswamy B Govindan; Srinivasan Vairavan; Bhargavi Sriram; James D Wilson; Hubert Preissl; Hari Eswaran
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

8.  A non-invasive multimodal foetal ECG-Doppler dataset for antenatal cardiology research.

Authors:  Eleonora Sulas; Monica Urru; Roberto Tumbarello; Luigi Raffo; Reza Sameni; Danilo Pani
Journal:  Sci Data       Date:  2021-01-26       Impact factor: 6.444

9.  Toward noninvasive monitoring of ongoing electrical activity of human uterus and fetal heart and brain.

Authors:  S Lew; M S Hämäläinen; Y Okada
Journal:  Clin Neurophysiol       Date:  2017-09-19       Impact factor: 3.708

10.  A systematic review of cardiac time intervals utilising non-invasive fetal electrocardiogram in normal fetuses.

Authors:  Vinayak Smith; Senthuran Arunthavanathan; Amrish Nair; Diane Ansermet; Fabricio da Silva Costa; Euan Morrison Wallace
Journal:  BMC Pregnancy Childbirth       Date:  2018-09-12       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.